London Daily

Focus on the big picture.
Thursday, Oct 09, 2025

FDA advisor explains why she voted against recommending Pfizer's Covid vaccine for emergency use

FDA advisor explains why she voted against recommending Pfizer's Covid vaccine for emergency use

Dr. Archana Chatterjee told CNBC on Friday she's "fully supportive" of emergency use authorization for people who are 18 years and older.


Dr. Archana Chatterjee, a member of the FDA advisory panel who voted against recommending Pfizer’s Covid-19 vaccine for emergency use, told CNBC on Friday that her opposition was because she did not believe 16- and 17-year-olds should be included right now.

In a “Squawk Box” interview, Chatterjee said she would have voted “yes” had the question before her been different. “I want to be very clear that I am fully supportive of the emergency use authorization for the use of this vaccine from Pfizer and BioNTech for adults 18 years and older,” said Chatterjee, a pediatric infectious disease specialist who serves as dean of the Chicago Medical School.

The FDA committee recommended emergency authorization of the vaccine for people who are 16 years old and older.

In addition to Chatterjee, three other members of a Food and Drug Administration advisory panel on Thursday voted against recommending U.S.-based Pfizer and German partner BioNTech’s vaccine for emergency use. One member abstained from voting, while 17 voted in favor of a recommendation.

The decision from the group of outside experts is nonbinding, but on Friday, FDA Commissioner Stephen Hahn said in a statement that the agency was working “rapidly” toward finalizing emergency use authorization.

The vaccine from Pfizer and BioNTech would be the first to receive regulatory clearance in the United States. It has already been granted approvals by health officials in the United Kingdom and Canada.

Chatterjee noted that the vaccine was 95% effective in preventing Covid-19 in clinical trials while also demonstrating a “really good safety profile overall.” She added, “I think that we were pleasantly surprised to see that this vaccine has such good efficacy in tens of thousands of participants that were included in the trial.”

While commending Pfizer and BioNTech for including people under age 18 in the trials, she stressed that she would like to have seen additional data before recommending more individuals in the group receive it.


Dr. Ofer Levy, director of the Precision Vaccines Program at Boston Children’s Hospital, was among the 17 outside experts who voted in favor of recommending the vaccine for emergency use. He told CNBC a “rigorous” safety review process took place, including for 16- and 17-year-olds.

“There was no particularly different safety signal for them as the older individuals so the majority of the committee members felt comfortable voting ‘yes,’” Levy said Friday on “Worldwide Exchange.”

“Yesterday was a milestone but there is a long road ahead” in the effort to end the coronavirus pandemic, Levy added. He pointed to the need for a large supply of Covid-19 vaccines so more people have the opportunity to be vaccinated, both in the U.S. and abroad.

Because doses of the Pfizer-BioNTech vaccine will be limited at first, concerns raised about younger individuals receiving it at this moment are “moot,” contended Dr. Scott Gottlieb, a Pfizer board member and former FDA chief. Health-care workers and residents of long-term care facilities are set to be first in line to get the shots.

“This vaccine isn’t going to be eligible for 16- and-17 year-olds for quite some time ... and probably until it gets fully licensed at some point, hopefully if everything goes well, in the spring and summertime,” Gottlieb said on “Squawk Box.”

The FDA’s advisory panel is set to meet next week on whether to recommend emergency use of Moderna’s Covid’s vaccine, which like Pfizer’s requires two shots and employs a new approach to inoculations that uses genetic material to provoke an immune response.


Newsletter

Related Articles

0:00
0:00
Close
France: Less Than a Month After His Appointment, the New French Prime Minister Resigns
Hungarian Prime Minister Viktor Orbán stated that Hungary will not adopt the euro because the European Union is falling apart.
Sarah Mullally Becomes First Woman Appointed Archbishop of Canterbury
Mayor in western Germany in intensive care after stabbing
Australian government pays Deloitte nearly half a million dollars for a report built on fabricated quotes, fake citations, and AI-generated nonsense.
US Prosecutors Gained Legal Approval to Hack Telegram Servers
Macron Faces Intensifying Pressure to Resign or Trigger New Elections Amid France’s Political Turmoil
Standard Chartered Names Roberto Hoornweg as Sole Head of Corporate & Investment Banking
UK Asylum Housing Firm Faces Backlash Over £187 Million Profits and Poor Living Conditions
UK Police Crack Major Gang in Smuggling of up to 40,000 Stolen Phones to China
BYD’s UK Sales Soar Nearly Nine-Fold, Making Britain Its Biggest Market Outside China
Trump Proposes Farm Bailout from Tariff Revenues Amid Backlash from Other Industries
FIFA Accuses Malaysia of Forging Citizenship Documents, Suspends Seven Footballers
Latvia to Bar Tourist and Occasional Buses to Russia and Belarus Until 2026
A Dollar Coin Featuring Trump’s Portrait Expected to Be Issued Next Year
Australia Orders X to Block Murder Videos, Citing Online Safety and Public Exposure
Three Scientists Awarded Nobel Prize in Medicine for Discovery of Immune Self-Tolerance Mechanism
OpenAI and AMD Forge Landmark AI-Chip Alliance with Equity Option
Munich Airport Reopens After Second Drone Shutdown
France Names New Government Amid Political Crisis
Trump Stands Firm in Shutdown Showdown and Declares War on Drug Cartels — Turning Crisis into Opportunity
Surge of U.S. Billionaires Transforms London’s Peninsula Apartments into Ultra-Luxury Stronghold
Pro Europe and Anti-War Babiš Poised to Return to Power After Czech Parliamentary Vote
Jeff Bezos Calls AI Surge a ‘Good’ Bubble, Urges Focus on Lasting Innovation
Japan’s Ruling Party Chooses Sanae Takaichi, Clearing Path to First Female Prime Minister
Sean ‘Diddy’ Combs Sentenced to Fifty Months in Prison Following Prostitution Conviction
Taylor Swift’s ‘Showgirl’ Launch Extends Billion-Dollar Empire
Trump Administration Launches “TrumpRx” Plan to Enable Direct Drug Sales at Deep Discounts
Trump Announces Intention to Impose 100 Percent Tariff on Foreign-Made Films
Altman Says GPT-5 Already Outpaces Him, Warns AI Could Automate 40% of Work
Singapore and Hong Kong Vie to Dominate Asia’s Rising Gold Trade
Trump Organization Teams with Saudi Developer on $1 Billion Trump Plaza in Jeddah
Manhattan Sees Surge in Office-to-Housing Conversions, Highest Since 2008
Switzerland and U.S. Issue Joint Assurance Against Currency Manipulation
Electronic Arts to Be Taken Private in Historic $55 Billion Buyout
Thomas Jacob Sanford Named as Suspect in Deadly Michigan Church Shooting and Arson
Russian Research Vessel 'Yantar' Tracked Mapping Europe’s Subsea Cables, Raising Security Alarms
New York Man Arrested After On-Air Confession to 2017 Parents’ Murders
U.S. Defense Chief Orders Sudden Summit of Hundreds of Generals and Admirals
Global Cruise Industry Posts Dramatic Comeback with 34.6 Million Passengers in 2024
Trump Claims FBI Planted 274 Agents at Capitol Riot, Citing Unverified Reports
India: Internet Suspended in Bareilly Amid Communal Clashes Between Muslims and Hindus
Supreme Court Extends Freeze on Nearly $5 Billion in U.S. Foreign Aid at Trump’s Request
Archaeologists Recover Statues and Temples from 2,000-Year-Old Sunken City off Alexandria
China Deploys 2,000 Workers to Spain to Build Major EV Battery Factory, Raising European Dependence
Speed Takes Over: How Drive-Through Coffee Chains Are Rewriting U.S. Coffee Culture
U.S. Demands Brussels Scrutinize Digital Rules to Prevent Bias Against American Tech
Ringo Starr Champions Enduring Beatles Legacy While Debuting Las Vegas Art Show
Private Equity’s Fundraising Surge Triggers Concern of European Market Shake-Out
Colombian President Petro Vows to Mobilize Volunteers for Gaza and Joins List of Fighters
×